General Information of DTT (ID: TTMAHD1)

DTT Name Relaxin receptor 1 (RXFP1) DTT Info
Gene Name RXFP1

Molecule-Related Drug & Molecule List

Molecule-Related Drug List
Molecule Type:
DTT
DTP
DME
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
2 Clinical Trial Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
RLX030 DMXIRA0 Acute heart failure BD10-BD13 Approval submitted [1]
AZD5462 DM2QQZO Cardiovascular disease BA00-BE2Z Phase 1 [2]
------------------------------------------------------------------------------------
1 Investigative Drug(s) Transported by This DTP
Drug Name Drug ID Indication ICD 11 Highest Status REF
ML290 DMPOX4Q Discovery agent N.A. Investigative [3]
------------------------------------------------------------------------------------
Molecule Interaction Atlas

References

1 Design of the RELAXin in acute heart failure study. Am Heart J. 2012 Feb;163(2):149-55.e1.
2 Clinical pipeline report, company report or official report of AstraZeneca
3 Discovery, optimization, and biological activity of the first potent and selective small-molecule agonist series of human relaxin receptor 1 (RXFP1). Probe Reports from the NIH Molecular Libraries Program [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2010.